Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Diaceutics ( (GB:DXRX) ) has provided an announcement.
Diaceutics PLC announced that all resolutions proposed at its Annual General Meeting were passed, reflecting strong shareholder support. The resolutions included re-electing directors, appointing auditors, and authorizing share allotments, indicating stable governance and strategic alignment with shareholder interests.
The most recent analyst rating on (GB:DXRX) stock is a Buy with a £200.00 price target. To see the full list of analyst forecasts on Diaceutics stock, see the GB:DXRX Stock Forecast page.
More about Diaceutics
Diaceutics is a technology and solutions provider to the pharma and biotech industry, offering an end-to-end commercialization solution for precision medicines. Their services include data analytics, scientific, and advisory services, all facilitated by their platform DXRX – The Diagnostics Network®.
Average Trading Volume: 115,203
Technical Sentiment Signal: Buy
Current Market Cap: £105.6M
Learn more about DXRX stock on TipRanks’ Stock Analysis page.